Literature DB >> 17991935

Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial.

Nudrat Noor Qureshi1, Juanita Hatcher, Nish Chaturvedi, Tazeen H Jafar.   

Abstract

OBJECTIVE: To determine the impact of a simple educational package for general practitioners on adherence to antihypertensive drugs.
DESIGN: Cluster randomised controlled trial.
SETTING: Six randomly selected communities in Karachi, Pakistan. PARTICIPANTS: 200 patients with hypertension taking antihypertensive drugs; 78 general practitioners. INTERVENTION: Care by general practitioners specially trained in management of hypertension compared with usual care. MAIN OUTCOME MEASURE: Correct dosing, defined as percentage of prescribed doses taken, measured with electronic medication event monitoring system (MEMS) bottle.
RESULTS: 200 patients were enrolled, and 178 (89%) successfully completed six weeks of follow-up. Adherence was significantly greater in the special care group than in the usual care group (unadjusted mean percentage days with correct dose 48.1%, 95% confidence interval 35.8% to 60.4%, versus 32.4%, 22.6% to 42.3%; P=0.048). Adherence was also higher among patients who had higher levels of education (P<0.001), were encouraged by family members (P<0.001), believed in the effect of drugs (P<0.001), and had the purpose of the drugs explained to them (P<0.001).
CONCLUSIONS: Special training of general practitioners in management of hypertension, emphasising good communication between doctors and patients, is more effective than usual care provided in the communities in Karachi. Such simple interventions should be adopted by other developing countries that are now facing an increasing burden of hypertension. TRIAL REGISTRATION: Clinical trials NCT00330408 [ClinicalTrials.gov].

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991935      PMCID: PMC2078673          DOI: 10.1136/bmj.39360.617986.AE

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  32 in total

1.  Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action).

Authors:  M Campbell; J Grimshaw; N Steen
Journal:  J Health Serv Res Policy       Date:  2000-01

Review 2.  Ethnic differences in hypertension and blood pressure control in the UK.

Authors:  D A Lane; G Y Lip
Journal:  QJM       Date:  2001-07

3.  How should hamsters run? Some observations about sufficient patient time in primary care.

Authors:  D Mechanic
Journal:  BMJ       Date:  2001-08-04

4.  The ASH Specialists Program: a progress report. American Society of Hypertension.

Authors:  Lawrence R Krakoff
Journal:  Am J Hypertens       Date:  2002-06       Impact factor: 2.689

5.  Physician Role in Lack of Awareness and Control of Hypertension.

Authors:  David J. Hyman; Valory N. Pavlik; Carlos Vallbona
Journal:  J Clin Hypertens (Greenwich)       Date:  2000-10       Impact factor: 3.738

6.  Equity in health care access to: assessing the urban health insurance reform in China.

Authors:  Gordon G Liu; Zhongyun Zhao; Renhua Cai; Tetsuji Yamada; Tadashi Yamada
Journal:  Soc Sci Med       Date:  2002-11       Impact factor: 4.634

7.  Hypertension guidelines and their limitations--the impact of physicians' compliance as evaluated by guideline awareness.

Authors:  J Hagemeister; C A Schneider; S Barabas; R Schadt; G Wassmer; G Mager; H Pfaff; H W Höpp
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

8.  Ethnic subgroup differences in hypertension in Pakistan.

Authors:  Tazeen H Jafar; Andrew S Levey; Fahim H Jafary; Franklin White; Asma Gul; Mohammad H Rahbar; Abdul Q Khan; Andrew Hattersley; Christopher H Schmid; Nish Chaturvedi
Journal:  J Hypertens       Date:  2003-05       Impact factor: 4.844

9.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  28 in total

1.  Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial.

Authors:  Tazeen H Jafar; Muhammad Islam; Rasool Bux; Neil Poulter; Juanita Hatcher; Nish Chaturvedi; Shah Ebrahim; Peter Cosgrove
Journal:  Circulation       Date:  2011-09-19       Impact factor: 29.690

2.  How usual is usual care in pragmatic intervention studies in primary care? An overview of recent trials.

Authors:  Antonia F H Smelt; Gerda M van der Weele; Jeanet W Blom; Jacobijn Gussekloo; Willem J J Assendelft
Journal:  Br J Gen Pract       Date:  2010-07       Impact factor: 5.386

3.  Improving adherence to drugs for hypertension.

Authors:  Knut Schroeder; Tom Fahey
Journal:  BMJ       Date:  2007-11-08

Review 4.  A systematic review of adherence to cardiovascular medications in resource-limited settings.

Authors:  Ashna D K Bowry; William H Shrank; Joy L Lee; Margaret Stedman; Niteesh K Choudhry
Journal:  J Gen Intern Med       Date:  2011-08-20       Impact factor: 5.128

Review 5.  Cardiovascular medication: improving adherence.

Authors:  Liam Glynn; Tom Fahey
Journal:  BMJ Clin Evid       Date:  2011-04-11

6.  Effects of daily adherence to antihypertensive medication on blood pressure control.

Authors:  Adam J Rose; Mark E Glickman; Meredith M D'Amore; Michelle B Orner; Dan Berlowitz; Nancy R Kressin
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-02-16       Impact factor: 3.738

Review 7.  Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review.

Authors:  Sarah L Cutrona; Niteesh K Choudhry; Margaret Stedman; Amber Servi; Joshua N Liberman; Troyen Brennan; Michael A Fischer; M Alan Brookhart; William H Shrank
Journal:  J Gen Intern Med       Date:  2010-05-13       Impact factor: 5.128

Review 8.  Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?

Authors:  Robert E Becker; Nigel H Greig; Ezio Giacobini
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

9.  Adherence to cardiovascular medications in the South Asian population: A systematic review of current evidence and future directions.

Authors:  Julia M Akeroyd; Winston J Chan; Ayeesha K Kamal; Latha Palaniappan; Salim S Virani
Journal:  World J Cardiol       Date:  2015-12-26

10.  Intensifying therapy for hypertension despite suboptimal adherence.

Authors:  Adam J Rose; Dan R Berlowitz; Meredith Manze; Michelle B Orner; Nancy R Kressin
Journal:  Hypertension       Date:  2009-07-06       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.